Critical Contrast: Pharma Bio Serv (OTCMKTS:PBSV) & Diamond Eagle Acquisition (OTCMKTS:ATCX)

Pharma Bio Serv (OTCMKTS:PBSV) and Diamond Eagle Acquisition (NASDAQ:ATCX) are both small-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation.

Insider and Institutional Ownership

11.1% of Diamond Eagle Acquisition shares are held by institutional investors. 51.4% of Pharma Bio Serv shares are held by company insiders. Comparatively, 18.3% of Diamond Eagle Acquisition shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Risk and Volatility

Pharma Bio Serv has a beta of 0.23, suggesting that its stock price is 77% less volatile than the S&P 500. Comparatively, Diamond Eagle Acquisition has a beta of 0.61, suggesting that its stock price is 39% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Pharma Bio Serv and Diamond Eagle Acquisition, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pharma Bio Serv 0 0 0 0 N/A
Diamond Eagle Acquisition 0 0 1 0 3.00

Profitability

This table compares Pharma Bio Serv and Diamond Eagle Acquisition’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Pharma Bio Serv 10.97% 10.10% 8.19%
Diamond Eagle Acquisition N/A -34.64% -1.22%

Earnings and Valuation

This table compares Pharma Bio Serv and Diamond Eagle Acquisition’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Pharma Bio Serv $19.51 million 0.99 $2.09 million $0.09 9.17
Diamond Eagle Acquisition N/A N/A -$350,000.00 N/A N/A

Pharma Bio Serv has higher revenue and earnings than Diamond Eagle Acquisition.

Summary

Pharma Bio Serv beats Diamond Eagle Acquisition on 6 of the 9 factors compared between the two stocks.

About Pharma Bio Serv

Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm the United States, Europe, and Brazil markets. It provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products in Puerto Rico, the United States, Europe, and Brazil. The company's technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.

About Diamond Eagle Acquisition

Atlas Technical Consultants, Inc. provides professional testing, inspection, engineering, program management, and consulting services in the United States. It offers materials engineering and testing, construction quality assurance, environmental, and disaster response and recovery services; and engineering and design, program management, and construction support services. The company offers its solutions to public and private sector clients in the transportation, commercial, water, government, education, and industrial markets under the Atlas Technical Consultants name. Atlas Technical Consultants, Inc. was incorporated in 2017 and is headquartered in Austin, Texas.

Receive News & Ratings for Pharma Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Bio Serv and related companies with MarketBeat.com's FREE daily email newsletter.